Ribon Therapeutics

Ribon Therapeutics

Ribon Therapeutics

Ribon is dedicated to the discovery and development of firstinclass small molecule inhibitors to block cancer cells' ability to survive under stress.
Raised
$65M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$65,000,000
Venture capital (Series B) - 2019
Celgene Osage University Partners Novartis Venture Fund +10
Team Size
1–10
Employees
$65,000,000 Venture capital (Series B)
PE HUB

Ribon Therapeutics lands $65 mln Series B